Holdings of the Fund as of 8/21/2025
Total Number of Holdings (excluding cash): 50
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
5,685 |
$74,500.46 |
3.65% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,997 |
$55,673.46 |
2.73% |
| Hoya Corporation |
7741.JP |
J22848105 |
394 |
$51,305.42 |
2.52% |
| ResMed Inc. |
RMD |
761152107 |
177 |
$51,036.18 |
2.50% |
| Insulet Corporation |
PODD |
45784P101 |
148 |
$48,521.80 |
2.38% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
37 |
$47,286.00 |
2.32% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
160 |
$45,604.80 |
2.24% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,655 |
$45,559.28 |
2.23% |
| Cochlear Limited |
COH.AU |
Q25953102 |
232 |
$45,256.71 |
2.22% |
| BioMerieux |
BIM.FP |
F1149Y232 |
303 |
$44,799.82 |
2.20% |
| DexCom, Inc. |
DXCM |
252131107 |
553 |
$44,582.86 |
2.19% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,122 |
$44,410.32 |
2.18% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
183 |
$44,401.29 |
2.18% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
545 |
$44,232.20 |
2.17% |
| Agilent Technologies, Inc. |
A |
00846U101 |
372 |
$43,579.80 |
2.14% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
597 |
$43,670.55 |
2.14% |
| Hologic, Inc. |
HOLX |
436440101 |
651 |
$43,727.67 |
2.14% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
212 |
$43,376.29 |
2.13% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
766 |
$42,484.47 |
2.08% |
| Steris Plc |
STE |
G8473T100 |
171 |
$42,322.50 |
2.08% |
| Boston Scientific Corporation |
BSX |
101137107 |
401 |
$42,189.21 |
2.07% |
| Danaher Corporation |
DHR |
235851102 |
206 |
$42,003.40 |
2.06% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,881 |
$42,067.45 |
2.06% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
87 |
$42,087.12 |
2.06% |
| Medtronic Plc |
MDT |
G5960L103 |
451 |
$41,086.10 |
2.02% |
| Stryker Corporation |
SYK |
863667101 |
107 |
$41,176.81 |
2.02% |
| Exact Sciences Corporation |
EXAS |
30063P105 |
850 |
$39,678.00 |
1.95% |
| Abbott Laboratories |
ABT |
002824100 |
299 |
$39,468.00 |
1.94% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
364 |
$38,008.88 |
1.86% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
132 |
$37,649.01 |
1.85% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
321 |
$37,415.94 |
1.84% |
| Becton, Dickinson and Company |
BDX |
075887109 |
187 |
$36,769.81 |
1.80% |
| The Cooper Companies, Inc. |
COO |
216648501 |
493 |
$36,008.72 |
1.77% |
| Revvity, Inc. |
RVTY |
714046109 |
400 |
$35,868.00 |
1.76% |
| Teleflex Incorporated |
TFX |
879369106 |
288 |
$35,887.68 |
1.76% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
76 |
$35,710.88 |
1.75% |
| Masimo Corporation |
MASI |
574795100 |
246 |
$35,483.04 |
1.74% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
406 |
$35,171.78 |
1.73% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
360 |
$34,666.23 |
1.70% |
| Penumbra, Inc. |
PEN |
70975L107 |
138 |
$34,689.06 |
1.70% |
| Olympus Corporation |
7733.JP |
J61240107 |
2,940 |
$34,479.14 |
1.69% |
| Terumo Corporation |
4543.JP |
J83173104 |
1,860 |
$34,343.47 |
1.68% |
| Waters Corporation |
WAT |
941848103 |
118 |
$34,271.92 |
1.68% |
| Alcon Inc. |
ALC.SW |
H01301128 |
428 |
$33,801.86 |
1.66% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
1,873 |
$33,181.73 |
1.63% |
| Align Technology, Inc. |
ALGN |
016255101 |
232 |
$32,635.44 |
1.60% |
| Baxter International Inc. |
BAX |
071813109 |
1,322 |
$31,529.70 |
1.55% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
524 |
$31,702.00 |
1.55% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
624 |
$30,661.94 |
1.50% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
1,934 |
$25,588.02 |
1.26% |
| US Dollar |
$USD |
|
7,211 |
$7,211.33 |
0.35% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|